San Diego-based Primmune Therapeutics, a biotech company, has raised $27.4 million in Series A financing. CAM Capital and Polaris Partners led the round with participation from other investors that included Samsara BioCapital, Oberland Capital, McDermott, BioRock Ventures and BioBrit.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: